structure based drug design
Structure-based drug design: aiming for a perfect fit.
7
Quantum mechanical methods for structure-based drug design
147
Structure based drug design for ndm1 inhibitors identification of antibacterial resistance
6
Structure Based Drug Design and Synthesis of Ibuprofen analogs as Cox Inhibitors
8
Analysis of Protein Structure based Drug Design Using Comparative Molecular Field Analysis
6
From Traditional Medicine to Modern Drugs: Historical Perspective of Structure-Based Drug Design
18
INACTIVATION OF USP (RV2623) PROTEIN OF MYCOBACTERIUM TUBERCULOSIS H37RV USING STRUCTURE –BASED DRUG DESIGN APPROACH
13
Dimorphite-DL and biotite-tools, two open source programs for the acceleration of structure-based drug design
41
Structure-based drug design studies of UDP-N-acetylglucosamine pyrophosphosrylase, a key enzyme for the control of witches’ broom disease
7
Protein Flexibility in Structure-Based Drug Design.
106
Combining Structure-Based Drug Design and Pharmacophores
18
Structure-based drug design strategies in medicinal chemistry
21
Incorporating Hotspot Mapping and Allostery in Structure Based Drug Design.
206
The development of sialidase inhibitors using structure based drug design
244
Computational structure‐based drug design: Predicting target flexibility
31
Structure-based drug design for the β 2 -adrenergic receptor
34
Structure-Based Drug Design of Quercetin and its Derivatives Against HMGB1
10
Virtual Ligand Screening for Structure-based Drug Design: Approaches and Progress
18
Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches
9
Supporting Information: 3D Convolutional Neural Networks and a. CrossDocked Data Set for Structure-Based Drug. Design
21